Abstract: A device for applying electric current to mass. The device includes a vessel having a cylindrical wall with a stirrer arranged in the vessel. The stirrer is mounted on a first end of a rotationally driven stirrer shaft. The stirrer shaft with a spacing is enclosed by a first electrode. The first electrode is immobile and fixed to a lid arranged to cover an open cross-section of the vessel. The cylindrical wall forms a second electrode, wherein the first electrode and the second electrode are connectable to opposite polarities of a current source.

Abstract: A composition may include at least one oligopeptide having solely alpha-peptide-bonds with one amino acid being cysteine (Cys), and free cysteine. A culture medium and may be used for culturing cells, preferably plant cells, animal cells, or mammalian cells, and a cell culture product may be manufactured using such a method.

Abstract: The invention relates to compositions comprising glycolipids and benzoic acid and/or sorbic acid.

Abstract: The present invention relates to oral care compositions comprising at least one biosurfactant and fluoride.

Abstract: The present invention relates to at least one cell for producing at least one lipid with general formula II from at least one carbon substrate, wherein R1 and R2 independently of one another comprises identical or different organic radicals each with 5 to 13 carbon atoms, wherein the cell is a non-pathogenic cell that is genetically modified to increase the heterologous expression relative to the wild type cell of: an enzyme (E2) capable of converting 3-hydroxyalkanoyl-3-hydroxyalkanoyl-CoA/ACP or 3-(3-hydroxyalkanoyloxy)alkanoic acid (HAA) and NDP-glucose into ?-D-glucopyranosyl-3-hydroxyalkanoyl-3-hydroxyalkanoate.

Abstract: A preparation containing a mixture of at least one phospholipid, and at least one fatty acid salt of a cation with an anion derived from a fatty acid. A method for preparing such preparation and the use of such preparation to provide polyunsaturated fatty acids to cells, tissues, organs or organisms, for example in the field of cell and tissue culture, organ preservation, human or animal nutrition, or cosmetics.

Abstract: The invention relates to preparation comprising at least one omega-3 or omega-6 fatty acid component selected from eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), alpha linolenic acid, stearidonic acid, eicosatetraenoic acid, docosapentaenoic acid, linoleic acid, ?-linolenic acid, or arachidonic acid (ARA) and/or derivatives thereof for use to increase the formation of one or more specialized pro-resolving lipid mediators (SPM) by gastrointestinal microorganisms in the gastrointestinal tract of humans or animals wherein the polyunsaturated fatty acid component comprises an omega-3 or omega-6 fatty acid salt.

Abstract: The invention relates to preparation comprising at least one probiotic strain belonging to the genus Bacillus megaterium, and a polyunsaturated fatty acid component comprising at least one omega-3 or omega-6 fatty acid selected from eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), arachidonic acid (ARA), alpha linolenic acid, stearidonic acid, eicosatetraenoic acid, docosapentaenoic acid, linoleic acid, ?-linolenic acid, wherein the polyunsaturated fatty acid component comprises an omega-3 or omega-6 fatty acid salt. The invention further relates to use of the inventive preparation as a feed or food supplement, pharmaceutical product, feed-or foodstuff compositions and for topical applications.

Abstract: The invention relates to a mixture composition comprising glucolipids, to its use for producing formulations and to formulations comprising this mixture composition.

Abstract: The invention relates to compositions comprising glycolipids and benzoic acid and/or sorbic acid.

Abstract: The invention relates to compositions comprising at least one protease and at least one biosurfactant, particularly selected from rhamnolipids and sophorolipids. In particular, the present invention is directed to a composition including A) at least one peptidase, B) at least one biosurfactant, and optionally C) at least one anionic surfactant. The peptidase may be selected from the group of the proteases, particularly from the group of the serine proteases of EC 3.4.21 and the metalloproteases of EC 3.4.24 and the biosurfactant may be selected from the group comprising rhamnolipids and sophorolipids.

Abstract: The present invention relates to at least one cell for producing at least one lipid with general formula II from at least one carbon substrate, wherein R1 and R2 independently of one another comprises identical or different organic radicals each with 5 to 13 carbon atoms, wherein the cell is a non-pathogenic cell that is genetically modified to increase the heterologous expression relative to the wild type cell of: an enzyme (E2) capable of converting 3-hydroxyalkanoyl-3-hydroxyalkanoyl-CoA/ACP or 3-(3-hydroxyalkanoyloxy)alkanoic acid (HAA) and NDP-glucose into ?-D-glucopyranosyl-3-hydroxyalkanoyl-3-hydroxyalkanoate.

Abstract: A rhamnolipid composition including 30% by weight to 70% by weight, of at least one rhamnolipid and 30% by weight to 70% by weight of water, where the percentages by weight refer to the total composition, wherein the pH of the composition at 25° C. is from 5.5 to 7.0. In addition to the foregoing rhamnolipid composition, also set forth is a method to make a solution of rhamnolipids; and salt of at least one rhamnolipid.

Abstract: The invention provides compositions comprising at least one rhamnolipid and at least one siloxane, characterized in that the weight ratio of rhamnolipid to siloxane is from 5,000,000:1 to 100:1, preferably from 500,000:1 to 1000:1, particularly preferably from 25,000:1 to 2500:1. In another embodiment, the invention provides compositions include rhamnolipid in an amount of from 0.5% by weight to 70% by weight, preferably from 2% by weight to 60% by weight, particularly preferably from 3% by weight to 50% by weight, where the percentages by weight refer to the total composition.

Abstract: The present invention relates to oral care compositions comprising at least one biosurfactant and fluoride.

Abstract: The invention relates to compositions comprising glycolipids and benzoic acid and/or sorbic acid.

Abstract: The invention relates to a mixture composition comprising rhamnolipids, to a process for its preparation, to its use for producing formulations and to formulations comprising this mixture composition.

Abstract: The invention relates to compositions comprising at least one protease and at least one biosurfactant, particularly selected from rhamnolipids and sophorolipids. In particular, the present invention is directed to a composition including A) at least one peptidase, B) at least one biosurfactant, and optionally C) at least one anionic surfactant. The peptidase may be selected from the group of the proteases, particularly from the group of the serine proteases of EC 3.4.21 and the metalloproteases of EC 3.4.24 and the biosurfactant may be selected from the group comprising rhamnolipids and sophorolipids.

Abstract: The invention provides compositions comprising at least one rhamnolipid and at least one siloxane, characterized in that the weight ratio of rhamnolipid to siloxane is from 5,000,000:1 to 100:1, preferably from 500,000:1 to 1000:1, particularly preferably from 25,000:1 to 2500:1. In another embodiment, the invention provides compositions include rhamnolipid in an amount of from 0.5% by weight to 70% by weight, preferably from 2% by weight to 60% by weight, particularly preferably from 3% by weight to 50% by weight, where the percentages by weight refer to the total composition.

Abstract: A rhamnolipid composition including 30% by weight to 70% by weight, of at least one rhamnolipid and 30% by weight to 70% by weight of water, where the percentages by weight refer to the total composition, wherein the pH of the composition at 25° C. is from 5.5 to 7.0. In addition to the foregoing rhamnolipid composition, also set forth is a method to make a solution of rhamnolipids; and a salt of at least one rhamnolipid.